FDA warns company over unapproved flu remedy

Federal regulators say a Florida company has been marketing an untested inhaled formula as a flu remedy in violation of drug safety regulations.

The and the Federal Trade Commission are warning Flu and Cold Defense for making misleading, unproven claims about its GermBullet inhaler.

The Boca Raton, Florida-based company advertises the product as a blend of 11 organic botanicals. It sells the product online and at certain pharmacies and grocery stores.

But say the mixture has never been reviewed as safe and effective and the company is violating regulations.

A man reached by phone at Flu and Cold Defense's office could not immediately comment on the warning letter.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA sends Procter & Gamble a warning

Sep 18, 2007

The U. S. Food and Drug Administration has warned the Procter & Gamble Co. about claims it makes for its Vicks Early Defense Foaming Hand Sanitizer.

FDA issues warning over-the-counter diarrhea drug

Sep 18, 2012

(AP)—The Food and Drug Administration is warning consumers not to use an over-the-counter drug called Intestinomicina because the anti-diarrhea treatment contains a drug linked to life-threatening injuries.

FDA cites claims on 2 green tea beverages

Sep 07, 2010

(AP) -- Federal health regulators have issued warnings to the makers of Canada Dry ginger ale and Lipton tea for making unsubstantiated nutritional claims about their green tea-flavored beverages.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

13 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.